Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/184578
Proresolving lipid mediators and liver disease.
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Inflammation is a characteristic feature of virtually all acute and chronic liver diseases. It intersects different liver pathologies from the early stages of liver injury, when the inflammatory burden is mild-to-moderate, to very advanced stages of liver disease, when the inflammatory response is very intense and drives multiple organ dysfunction and failure(s). The current review describes the most relevant features of the inflammatory process in two different clinical entities across the liver disease spectrum, namely non-alcoholic steatohepatitis (NASH) and acute-on-chronic liver failure (ACLF). Special emphasis is given within these two disease conditions to gather the most relevant data on the specialized pro-resolving mediators that orchestrate the resolution of inflammation, a tightly controlled process which dysregulation commonly associates with chronic inflammatory conditions.
Matèries
Matèries (anglès)
Citació
Citació
CLÀRIA I ENRICH, Joan, FLORES COSTA, Roger, DURAN GÜELL, Marta, LÓPEZ VICARIO, Cristina. Proresolving lipid mediators and liver disease.. _Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids_. 2021. Vol. 1866, núm. 11, pàgs. 159023. [consulta: 24 de gener de 2026]. ISSN: 1388-1981. [Disponible a: https://hdl.handle.net/2445/184578]